Dr. Zeidan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Wright State Physicians
5678 Far Hills Ave
Dayton, OH 45429Phone+1 937-245-7200Fax+1 866-777-4959
Summary
- Dr. Trisha Zeidan is an endocrinologist in Dayton, OH and is affiliated with Miami Valley Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 13 years. She specializes in diabetes and lipid metabolism.
Education & Training
- Ohio State University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
- Ohio State University HospitalResidency, Internal Medicine, 2004 - 2007
- Ohio State University College of MedicineClass of 2004
Certifications & Licensure
- OH State Medical License 2004 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 13 citationsDeterminants of the accuracy of continuous glucose monitoring in non-critically ill patients with heart failure or severe hyperglycemia.Kathleen Dungan, Wen Han, Anthony Miele, Trisha Zeidan, Karen Weiland
Journal of Diabetes Science and Technology. 2012-07-01 - 2 citationsClinical Evaluation of Basal-Bolus Therapy Delivered by the V-Go® Wearable Insulin Delivery Device in Patients with Type 2 Diabetes: A Retrospective AnalysisTrisha Zeidan, Carla Nikkel, Beth Dziengelewski, Stephanie Wu, Aleda M.H. Chen
Pharmacy. 2020-11-14
Press Mentions
- 10 New Ways Medtech Could Keep Diabetes in CheckNovember 22nd, 2019
- Valeritas' V-go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 When Intensifying from a Basal Insulin Regimen to Basal-Bolus DeliveryJune 27th, 2019
- Medtronic's Latest Real-World Device Data, Onduo and Orpyx's Expanding Partnership and More Diabetes News from ADA 2019June 10th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: